Targeted CD4+CD25+ Tregs significantly reduced AHR, airway eosinophilia, mucus hyper-secretion, Th2 cytokine production, and allergen-specific IgE after sensitization with a model allergen. Here, CD4 is linked to Increased total eosinophil count.